Celltrion receives approval for infliximab biosimilar antibody from Brazils ANVISA Hospira.

Celltrion receives approval for infliximab biosimilar antibody from Brazil’s ANVISA Hospira, Inc http://doxycycline-hcl.com/doxycycline-vs-stds-prostatitis-and-endometritis.html . The medication will be marketed by Hospira. Hospira also marketplaces and sells biosimilar infliximab in 26 Europe and in Canada under the brand Inflectra. This important product has been approved in Brazil for the treatment of: arthritis rheumatoid, ankylosing spondylitis, psoriasis, psoriatic arthritis, Crohn's disease in kids and adults, fistulizing Crohn's disease , colitis and ulcerative rectocolitis.


Wellness plans that step of progress to participate in NCQA's Health Plan Accreditation program in early stages in their history are to be especially commended, said Margaret E. O'Kane, President, NCQA. Our criteria are rigorous, and by meeting them, Sunflower shows that it is well designed and severe about the standard of care it offers. .. Centene’s Kansas subsidiary receives NCQA Health Plan Accreditation Centene Corporation has announced that its wholly owned Kansas subsidiary, Sunflower Health Plan, has received Accreditation from the National Committee for Quality Assurance . Receiving NCQA Accreditation is certainly a testament to our commitment to high-quality care coordination that leads to better wellness outcomes for Kansans, stated Dr. Michael D. McKinney, Plan President and CEO of Sunflower Health Plan.

Other entries from category "hematology":

Random entries